Equilis Resequin
Respiratory disease can result in poor performance or even an inability for the horse to reach an event. Transmission of the viruses occurs by direct or indirect contact with the infective discharges of affected animals. An estimated 75% of horses in the UK are ‘carriers’ of the herpes virus, those that show few symptoms but are capable of shedding virus into their surrounds. The disease caused by a herpes viral infection will present when triggered by stress factors such as training, transport and horse shows/racing events. A practical ‘whole herd’ approach to vaccination is often recommended by your veterinary surgeon.
Legal Category: POM-V
Equilis Resequin is an aqueous suspension for intramuscular injection. It contains inactivated antigens of equine influenza virus A/Equi 1/Prague 56, A/Equi 2/Newmarket 1/93 (American type strain), A/Equi 2/Newmarket 2/93 (European type strain), and inactivated herpes virus types 1 (EHV-1) and 4 (EHV-4).For uses, dosage, contra-indications and warnings, see datasheet. Equilis Resequin may only be prescribed and administered by your veterinary surgeon from whom advice should be sought. Further information is available on request.
Equilis Resequin is an aqueous suspension for intramuscular injection. It contains inactivated antigens of equine influenza virus A/Equi 1/Prague 56, A/Equi 2/Newmarket 1/93 (American type strain), A/Equi 2/Newmarket 2/93 (European type strain), and inactivated herpes virus types 1 (EHV-1) and 4 (EHV-4).For uses, dosage, contra-indications and warnings, see datasheet. Equilis Resequin may only be prescribed and administered by your veterinary surgeon from whom advice should be sought. Further information is available on request.
Company
